Alport syndrome: facts and opinions.
In this commentary, I review recent advances in Alport syndrome genetics, diagnostics, and therapeutics. I also offer some opinions regarding strategies to optimize the early identification of affected individuals to promote early therapeutic intervention.
Department of Pediatrics, Division of Pediatric Nephrology, University of Minnesota Medical School, Minneapolis, MN, USA.
Clifford
C
Kashtan
Alport syndrome; COL4A3; COL4A4; COL4A5; collagen IV alpha-345 network; end-stage renal disease